Location History:
- Solon, OH (US) (2000 - 2019)
- Cleveland, OH (US) (2017 - 2022)
Company Filing History:
4 out of 1,039 
1 out of 451 
1 out of 832,891 Years Active: 2000-2022
Title: Innovations and Contributions of Inventor Xiaoxia Li
Introduction
Xiaoxia Li is a prominent inventor based in Cleveland, OH (US). She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies and screening methods. With a total of 6 patents to her name, her work has the potential to impact various medical conditions.
Latest Patents
Among her latest patents is the invention of transgenic mice with inducible neuron-specific inactivation of the HuR gene. This patent provides non-human transgenic animals that can under-express or not express the HuR gene in specific neurons. These animals are valuable for screening drugs and therapies, particularly those useful in treating amyotrophic lateral sclerosis (ALS). Another notable patent involves SBE aptamers for treating IL-17a related diseases and conditions. This invention includes compositions, systems, kits, and methods that utilize an SBE nucleic acid sequence to bind a SEFIR domain of an ACT1 protein, offering new avenues for treatment.
Career Highlights
Xiaoxia Li has worked at the Cleveland Clinic Foundation, where she has been involved in groundbreaking research. Her work has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
Throughout her career, Xiaoxia has collaborated with notable colleagues, including Caini Liu and Tomasz Herjan. These partnerships have contributed to the advancement of her research and the successful development of her patents.
Conclusion
Xiaoxia Li's contributions to the field of biomedical research through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for innovative treatments and therapies that can significantly improve patient outcomes.